Frank Takkinen
Stock Analyst at Lake Street
(0.93)
# 3,965
Out of 5,182 analysts
78
Total ratings
26.76%
Success rate
-15.93%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMTI Sanara MedTech | Initiates: Buy | $32 | $20.62 | +55.19% | 1 | Apr 15, 2026 | |
| TELA TELA Bio | Maintains: Buy | $3 → $2 | $0.63 | +216.96% | 4 | Mar 25, 2026 | |
| HYPR Hyperfine | Maintains: Buy | $2 → $2.5 | $1.29 | +93.80% | 3 | Mar 19, 2026 | |
| TNDM Tandem Diabetes Care | Upgrades: Buy | $50 | $21.24 | +135.40% | 1 | Feb 23, 2026 | |
| NOTV Inotiv | Maintains: Buy | $3 → $1.5 | $0.29 | +423.38% | 9 | Feb 10, 2026 | |
| RCEL AVITA Medical | Maintains: Hold | $3 → $3.5 | $5.00 | -30.00% | 2 | Jan 16, 2026 | |
| BBNX Beta Bionics | Maintains: Buy | $35 → $40 | $12.91 | +209.84% | 2 | Jan 9, 2026 | |
| KRMD KORU Medical Systems | Maintains: Buy | $6 → $8 | $4.26 | +87.79% | 3 | Dec 22, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $7 → $12 | $4.36 | +175.23% | 7 | Dec 10, 2025 | |
| AXGN Axogen | Maintains: Buy | $30 → $40 | $37.23 | +7.44% | 2 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.53 | +161.44% | 1 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.42 | +181.69% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $1.12 | +435.71% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $150 | $56.97 | +163.30% | 2 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $10.79 | +122.43% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $14 | $7.24 | +93.37% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $5.55 | +170.27% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $13.38 | +94.32% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $11.16 | +168.82% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $5.92 | +237.84% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.35 | +270.37% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $38.80 | -22.68% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.70 | +759.23% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.98 | +102.02% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $16.53 | -27.40% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $3.92 | +129.59% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $3.42 | +367.84% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $923 → $277 | $9.44 | +2,833.26% | 2 | Jan 18, 2023 |
Sanara MedTech
Apr 15, 2026
Initiates: Buy
Price Target: $32
Current: $20.62
Upside: +55.19%
TELA Bio
Mar 25, 2026
Maintains: Buy
Price Target: $3 → $2
Current: $0.63
Upside: +216.96%
Hyperfine
Mar 19, 2026
Maintains: Buy
Price Target: $2 → $2.5
Current: $1.29
Upside: +93.80%
Tandem Diabetes Care
Feb 23, 2026
Upgrades: Buy
Price Target: $50
Current: $21.24
Upside: +135.40%
Inotiv
Feb 10, 2026
Maintains: Buy
Price Target: $3 → $1.5
Current: $0.29
Upside: +423.38%
AVITA Medical
Jan 16, 2026
Maintains: Hold
Price Target: $3 → $3.5
Current: $5.00
Upside: -30.00%
Beta Bionics
Jan 9, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $12.91
Upside: +209.84%
KORU Medical Systems
Dec 22, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $4.26
Upside: +87.79%
Sight Sciences
Dec 10, 2025
Maintains: Buy
Price Target: $7 → $12
Current: $4.36
Upside: +175.23%
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $37.23
Upside: +7.44%
Dec 2, 2025
Initiates: Buy
Price Target: $4
Current: $1.53
Upside: +161.44%
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.42
Upside: +181.69%
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $1.12
Upside: +435.71%
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $56.97
Upside: +163.30%
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $10.79
Upside: +122.43%
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $7.24
Upside: +93.37%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $5.55
Upside: +170.27%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $13.38
Upside: +94.32%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $11.16
Upside: +168.82%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $5.92
Upside: +237.84%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $1.35
Upside: +270.37%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $38.80
Upside: -22.68%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.70
Upside: +759.23%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $1.98
Upside: +102.02%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $16.53
Upside: -27.40%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.92
Upside: +129.59%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $3.42
Upside: +367.84%
Jan 18, 2023
Maintains: Buy
Price Target: $923 → $277
Current: $9.44
Upside: +2,833.26%